Trial Profile
Phase II trial of CB 1922 [SpirH] +/- conventional antiretrovirals in patients with early-stage HIV-1 infections
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 15 Oct 2007
Price :
$35
*
At a glance
- Drugs CB 1922 (Primary) ; Antiretrovirals
- Indications HIV-1 infections
- Focus Therapeutic Use
- 15 Oct 2007 New trial record.